Iván Álava

Iván Álava is a young biochemist dedicated to contributing to people's health and welfare through research and innovation. With a strong background in molecular biology and biochemistry, Iván has a passion for improving patient's lives through the production of safe and effective medicines. He has nearly 2 years of experience in lung cancer and COVID-19 research, which has fueled his desire to transition into the biopharmaceutical industry.

Iván holds a Master's degree in Molecular Biology from Universidad Autónoma de Madrid, a Bachelor's degree in Biochemistry from Universidad de Navarra, and another Bachelor's degree in Biochemistry from Nottingham Trent University. His academic achievements reflect his commitment to gaining a comprehensive understanding of the field.

Professionally, Iván has worked as a researcher at prestigious institutions like the National Center for Biotechnology-CSIC in Madrid, Spain, and Cima Universidad de Navarra. He is known for his proficiency in communication, teamwork, and project efficiency, making him a valuable asset to any collaborative environment.

Driven by a desire to be part of a dynamic and motivated team, Iván seeks opportunities in the biopharmaceutical sector where he can apply his knowledge and skills to develop innovative medicines that positively impact patient outcomes. His ultimate goal is to contribute to the advancement of healthcare and make a difference in people's lives.